Please login to the form below

Not currently logged in
Email:
Password:

cardiovascular

This page shows the latest cardiovascular news and features for those working in and with pharma, biotech and healthcare.

Amarin up as FDA speeds Vascepa’s cardiovascular claim review

Amarin up as FDA speeds Vascepa’s cardiovascular claim review

The new filing is based on the stellar results of the REDUCE-IT trial in more than 8, 000 statin-treated adults with elevated cardiovascular risk, reported last year. ... It achieved a reduction of 25% in major adverse cardiovascular events (MACE) and a

Latest news

More from news
Approximately 38 fully matching, plus 850 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 69 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 54 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 44 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics